J. Brunet

Function preservation in stage III squamous laryngeal carcinoma: Results with an induction chemotherapy protocol

M. Quer, M. Vega, F. Guedea, 1995, The Laryngoscope.

Chemotherapy and radiotherapy in locally advanced cervical cancer.

B. Ojeda, A. Lacasta, M. Llanos, 1995, Acta oncologica.

Pustules and Sinus Tracts Involving the Right Arm of an Elderly Patient Diagnosis : Eumycetoma

F. Petrella, M. R, Lee, 2012 .

Diffuse hyperkeratosis in a deaf and blind 48-year-old woman-diagnosis.

F. Petrella, M. R, Lee, 2012, Archives of dermatology.

A single center experience with high-dose (HD) IL-2 treatment for patients with advanced melanoma and pilot investigation of a novel gene expression signature as a predictor of response.

R. Sullivan, M. Atkins, E. Gardiner, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CHOP chemotherapy of intermediate and high-grade non-Hodgkin's lymphoma.

J. Tabernero, C. Pallarés, M. Llanos, 1994, Acta oncologica.

[Dermatomyositis and head and neck neoplasia].

R. Mesía, A. López Pousa, C. Sola, 1995, Revista clinica espanola.

[Esthesioneuroblastoma: experience from 4 cases treated with radiotherapy and neoadjuvant chemotherapy].

R. Mesía, X. León, L. de Andrés, 1995, Acta otorrinolaringologica espanola.

Treatment of oesophageal cancer with preoperative chemoradiotherapy may increase operative mortality.

E. Gallardo, R. Salazar, J. Balmaña, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer.

J. Tabernero, R. Mesía, A. López-pousa, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic Factors of Peripheral Blood Stem Cell Mobilization with Cyclophosphamide and Filgrastim (r-metHuG-CSF): The CD34+ Cell Dose Positively Affects the Time to Hematopoietic Recovery and Supportive Requirements after High-Dose Chemotherapy

R. Salazar, J. Tabernero, J. Cancelas, 1999 .

Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation

R. Salazar, P. Maroto, M. Rodriguez, 1999, Bone Marrow Transplantation.

Bone Marrow Transplantation: Prognostic Factors of Peripheral Blood Stem Cell Mobilization with Cyclophosphamide and Filgrastim (r-metHuG-CSF): The CD34+ Cell Dose Positively Affects the Time to Hematopoietic Recovery and Supportive Requirements after High-Dose Chemotherapy.

R. Salazar, J. Tabernero, J. Cancelas, 1999, Hematology.

CA-125 Response Patterns in Patients With Recurrent Ovarian Cancer Treated With Pegylated Liposomal Doxorubicin (PLD)

M. Alsina, A. Oaknin, P. Barretina, 2009, International Journal of Gynecologic Cancer.